By David Tuller, DrPH As I wrote yesterday, Mahana Therapeutics has recently licensed from King’s College London an “innovative digital therapeutic”, a web-based program delivering a course of cognitive behavioral therapy to patients with irritable bowel syndrome. A page on the Mahana site promoting this web-delivered IBS-CBT program furthers the impression that this deal is …
Trial By Error: More on the Mahana Therapeutics Deal Read More »
By David Tuller, DrPH On January 10th, the following information was announced in a press release: Mahana Therapeutics, a digital therapeutics company reimagining the treatment of chronic diseases, today announced that the Company has entered into a licensing and collaboration agreement with King’s College London, a leading research university and one of the oldest and …
Trial By Error: A Commercial Deal for King’s College London’s IBS-CBT Digital Program Read More »
By David Tuller, DrPH Had things gone as planned, the PACE trial should have been able to serve as proof that so-called medically unexplained symptoms (MUS), in this case what the investigators referred to as chronic fatigue syndrome–could be successfully treated with psychological and behavioral therapies. The Lancet published the first PACE results, which reported …
Trial By Error: CBT and Irritable Bowel Syndrome Read More »
By David Tuller, DrPH Since 2008, the National Health Service (NHS) in England has been rolling out a program known as Improving Access to Psychological Therapies (IAPT). Initially focused on patients with mental health issues like depression and anxiety disorders, IAPT was then expanded to include those who are also simultaneously suffering from “long-term conditions” …
Trial By Error: CBT Provides No Benefits to Advanced Cancer Patients, Study Finds Read More »
By David Tuller, DrPH In the UK, leading researchers are preparing to submit an application for a large genetic study to two major funding agencies. The project is being led by Professor Chris Ponting of the University of Edinburgh, who is also vice chair of the CFS/ME Research Collaborative, and the UK ME/CFS Biobank at …
Trial By Error: The UK’s Proposed Genetics Study Read More »
A new coronavirus appears to be causing a pneumonia-like illness in China. It is certainly a zoonotic infection – jumping from non-human animals to humans – as exemplified by previous outbreaks of SARS and MERS coronaviruses.
